Warner Chilcott Logo

Print Print page   E-mail E-mail page   PDF Download PDF    Add to Briefcase
« Previous Release | Next Release »



Warner Chilcott to Present at the 30th Annual J.P. Morgan Healthcare Conference

DUBLIN, Ireland, Jan. 4, 2012 (GLOBE NEWSWIRE) -- Warner Chilcott plc (Nasdaq:WCRX) today announced that its President, Europe/International and Global Marketing, Hans Van Zoonen, and its Executive Vice President and Chief Financial Officer, Paul Herendeen, are scheduled to speak at the 30th Annual J.P. Morgan Healthcare Conference on Tuesday, January 10th at 8:30 a.m. PST (11:30 a.m. EST).

The presentation will be simultaneously webcast at http://ir.wcrx.com/events.cfm, with an archived replay of the webcast available shortly thereafter at http://ir.wcrx.com/events.cfm.

The Company

Warner Chilcott is a leading specialty pharmaceutical company currently focused on the women's healthcare, gastroenterology, dermatology and urology segments of the North American and Western European pharmaceuticals markets. The Company is fully integrated with internal resources dedicated to the development, manufacturing and promotion of its products. WCRX-G

CONTACT: Company Contact:

         Emily Hill

         Investor Relations

         973-907-7084

         Emily.Hill@wcrx.com

Close window | Back to top